Cross-sectional imaging characteristics of pituitary adenomas, invasive adenomas and adenocarcinomas in dogs: 33 cases (1988-2006)

Journal of Veterinary Internal Medicine

Volumn 24, Issue 1, 2010, Pages 160-165

  Pollard, Rachel E ^a   Reilly, Christopher M ^a   Uerling, Megan R ^a   Wood, Farica D ^a   Feldman, Edward C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CT; Endocrinology; Mri; Pathology

Indexed keywords

CONTRAST MEDIUM;

ADENOCARCINOMA; ADENOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOG; DOG DISEASE; HYPOPHYSIS TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RADIOGRAPHY;

ADENOCARCINOMA; ADENOMA; ANIMALS; CONTRAST MEDIA; DOG DISEASES; DOGS; MAGNETIC RESONANCE IMAGING; PITUITARY NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

ANIMALIA; CANIS FAMILIARIS;

EID: 73349087532     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2009.0414.x     Document Type: Article

References (20)

1. Duesberg CA, Feldman EC, Nelson RW, et al. Magnetic resonance imaging for diagnosis of pituitary macrotumors in dogs. J Am Vet Med Assoc 1995;206:657-662.
2. Mauldin GN, Burk RL. The use of diagnostic computerized tomography and radiation therapy in canine and feline hyperadrenocorticism. Probl Vet Med 1990;2:557-564.
3. Thuomas KA. Pituitary microadenoma. MR appearance and correlation with CT. Acta Radiol 1999;40:663.
4. Feldman EC, Nelson RW. Canine and Feline Endocrinology and Reproduction, 3rd ed. Philadelphia, PA: WB Saunders Co; 2003.
5. Nelson RW, Ihle SL, Feldman EC. Pituitary macroadenomas and macroadenocarcinomas in dogs treated with Lysodren for pituitary-dependent hyperadrenocorticism: 13 cases (1981-1986). J Am Vet Med Assoc 1989;194:1612-1617.
6. Burger PC, Scheithauer BW, Vogel FS. Region of the Sella Turcica. Surgical Pathology of the Nervous System and its Coverings, 4th ed. Philadelphia, PA: Elsevier Science; 2002.
7. Kontogeorgos G. Classification and pathology of pituitary tumors. Endocrine 2005;28:27-35.
8. Pernicone PJ, Scheithauer BW, Sebo TJ, et al. Pituitary carcinoma: A clinicopathologic study of 15 cases. Cancer 1997;79:804-812.
9. Kiupel M, Capen CC, Miller M, et al. Histological Classification of Tumors of the Endocrine System of Domestic Animals, 2nd Series. Washington, DC: Armed Forces Institute of Pathology; 2008.
10. Greco DS, Behrend EN, Brown SA, et al. Pharmacokinetics of exogenous corticotropin in normal dogs, hospitalized dogs with non adrenal illness and adrenopathic dogs. J Vet Pharmacol Ther 1998;21:369-374.
11. Kooistra HS, Voorhout G, Mol JA, et al. Correlation between impairment of glucocorticoid feedback and the size of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. J Endocrinol 1997;152:387-394.
12. Li-Ng M, Sharma M. Invasive pituitary adenoma. J Clin Endocrinol Metab 2008;93:3284-3285.
13. Lopes MB, Scheithauer BW, Schiff D. Pituitary carcinoma: Diagnosis and treatment. Endocrine 2005;28:115-121.
14. Meij BP, Lopes MB, Ellegala DB, et al. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. J Neurosurg 2002;96:195-208.
15. Thapar K, Kovacs K, Scheithauer BW, et al. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: An analysis using the MIB-1 antibody. Neurosurgery 1996;38:99-106.
16. Wood FD, Pollard RE, Uerling MR, et al. Diagnostic imaging findings and endocrine test results in dogs with pituitary-dependent hyperadrenocorticism that did or did not have neurologic abnormalities: 157 cases (1989-2005). J Am Vet Med Assoc 2007;231:1081-1085.
17. Hanson JM, van't HM, Voorhout G, et al. Efficacy of transsphenoidal hypophysectomy in treatment of dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 2005;19:687-694.
18. Hanson JM, Teske E, Voorhout G, et al. Prognostic factors for outcome after transsphenoidal hypophysectomy in dogs with pituitary-dependent hyperadrenocorticism. J Neurosurg 2007;107:830-840.
19. Theon AP, Feldman EC. Megavoltage irradiation of pituitary macrotumors in dogs with neurologic signs. J Am Vet Med Assoc 1998;213:225-231.
20. Kent MS, Bommarito D, Feldman E, et al. Survival, neurologic response, and prognostic factors in dogs with pituitary masses treated with radiation therapy and untreated dogs. J Vet Intern Med 2007;21:1027-1033.